Operating Lease, Right-of-Use Asset of Keros Therapeutics, Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Keros Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Keros Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $16,841,000, a 13% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Keros Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $16,841,000 -$2,410,000 -13% 31 Dec 2025 10-K 04 Mar 2026 2025 FY
Q3 2025 $17,463,000 -$2,360,000 -12% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $18,072,000 +$3,423,000 +23% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $18,667,000 +$3,672,000 +24% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $19,251,000 +$3,917,000 +26% 31 Dec 2024 10-K 04 Mar 2026 2025 FY
Q3 2024 $19,823,000 +$4,154,000 +27% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $14,649,000 -$1,361,000 -8.5% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $14,995,000 -$1,369,000 -8.4% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $15,334,000 -$214,000 -1.4% 31 Dec 2023 10-K 26 Feb 2025 2024 FY
Q3 2023 $15,669,000 +$15,222,000 +3405% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 $16,010,000 +$15,352,000 +2333% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $16,364,000 +$15,500,000 +1794% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $15,548,000 +$14,481,000 +1357% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $447,000 -$818,000 -65% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $658,000 -$18,000 -2.7% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $864,000 +$85,000 +11% 31 Mar 2022 10-Q 05 May 2022 2021 Q1
Q4 2021 $1,067,000 +$189,000 +22% 31 Dec 2021 10-K 03 Mar 2023 2022 FY
Q3 2021 $1,265,000 +$289,000 +30% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $676,000 -$349,000 -34% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $779,000 -$337,000 -30% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $878,000 -$327,000 -27% 31 Dec 2020 10-K 09 Mar 2022 2021 FY
Q3 2020 $976,000 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 $1,025,000 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 $1,116,000 31 Mar 2020 10-Q 22 May 2020 2020 Q1
Q4 2019 $1,205,000 31 Dec 2019 10-K 25 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.